JPRN-UMIN000045479招募中未知
A Phase II Single-Arm Study to Evaluate the Feasibility of Preoperative Rehabilitation and Nutrition Intervention in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer - RENUAL trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Infectious disease requiring systemic treatment. (Because rehabilitation is difficult) 2. Patient has a fever of 38 degrees Celsius or higher. (Due to difficulty in rehabilitation) Patient has poorly controlled diabetes mellitus (HbA1c of 6.5% or higher is the standard). (Due to difficulty in nutritional intervention) 4. Complicated psychosis or psychiatric symptoms, which will make it difficult to participate in the study. (Due to difficulty in rehabilitation) 5. Patient has poorly controlled hypertension. (Due to difficulty in rehabilitation) 6. Patient has unstable angina (angina pectoris with onset or worsening within the last 3 weeks) or myocardial infarction within the last 6 months. (Due to difficulty in rehabilitation) 7. Patient has interstitial pneumonia, pulmonary fibrosis, severe emphysema, or heart failure. (Due to difficulty in rehabilitation) 8. Patient has a history of cerebrovascular disease (cerebral infarction, intracerebral hemorrhage, transient ischemic attack, etc.) that occurred within 6 months. (Due to difficulty in rehabilitation) 9. Other patients who are deemed unsuitable for enrollment in this clinical trial by the physician in charge.
研究者
相似试验
尚未招募
不适用
A Phase II Single-Arm Study to Evaluate the Feasibility of Preoperative Rehabilitation and Nutrition Intervention in Patients Undergoing Resection for Hepato-Pancreato-Biliary Surgeries.HBP malignancies (major hepatectomy, pancreatoduodenectomy)JPRN-UMIN000048073Keio University60
招募中
不适用
Clinical study to determine the appropriateness of a starting dose of 160 mg/day of lazertinib in patients with EGFR T790M-positive non-small cell lung cancerNeoplasmsKCT0008332Samsung Medical Center117
尚未招募
2 期
Dose-Dense ABVD Study: An accelerated delivery of Adriamycin, Bleomycin, Vinblastin and Dacarbazine for patients with Hodgkin LymphomaEarly Stage Unfavourable Hodgkin LymphomaAdvanced Stage Hodgkin LymphomaCancer - Hodgkin'sACTRN12612000137897Queensland Health31
进行中(未招募)
1 期
A Study of Avapritinib in Pediatric Patients with Solid Tumors Dependent on KIT or PDGFRA SignalingSolid Tumors Dependent on KIT or PDGFRA SignalingMedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 100000004864EUCTR2020-005234-15-ITBLUEPRINT MEDICINES CORPORATIO37
进行中(未招募)
1 期
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA SignalingCTIS2023-508617-16-00Blueprint Medicines Corp.37
